Perzinfotel
Perzinfotel is a drug that was under development for the treatment of stroke and migraine. It acts as an NMDA antagonist, specifically blocking the glutamate site on the NMDA receptor, which is one of the subtypes of glutamate receptor. This makes it a noncompetitive antagonist.
History[edit | edit source]
Perzinfotel was developed by the pharmaceutical company Eli Lilly. It reached Phase II clinical trials for the treatment of acute ischemic stroke and migraine, but development was discontinued due to lack of efficacy.
Mechanism of action[edit | edit source]
Perzinfotel works by blocking the glutamate site on the NMDA receptor, one of the subtypes of glutamate receptor. This makes it a noncompetitive antagonist. The NMDA receptor is a major subtype of glutamate receptor, and it plays a key role in the transmission of electrical signals in the brain. By blocking this receptor, perzinfotel can potentially reduce the damage caused by excessive glutamate release, which is a common feature of many neurological disorders, including stroke and migraine.
Clinical trials[edit | edit source]
Perzinfotel reached Phase II clinical trials for the treatment of acute ischemic stroke and migraine. However, development was discontinued due to lack of efficacy. In the clinical trials, perzinfotel was found to be safe and well-tolerated, but it did not show significant benefits in reducing the symptoms of stroke or migraine.
See also[edit | edit source]
| Perzinfotel Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
